A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU group protocol 30867

Sophie D. Fosså; Ted Splinter; Klaas J. Roozendaal; Kees H. N. Veenhof; Michele Pavone-Macaluso; Alessandro Calciati; Marleen de Pauw; Richard Sylvester

doi:10.1016/0277-5379(89)90035-7

A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU group protocol 30867

Sophie D. Fosså
, Ted Splinter
, Klaas J. Roozendaal
, Kees H. N. Veenhof
, Michele Pavone-Macaluso
, Alessandro Calciati
, Marleen de Pauw
, Richard Sylvester

University of Oslo
Erasmus MC
Afd. Radiologie: Onze Lieve Vrouwe Gasthuis
Amsterdam UMC - University of Amsterdam
University of Palermo
Azienda Sanitaria Ospedaliera Molinette San Giovanni Battista Di Torino
European Organisation for Research and Treatment of Cancer Data Center

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	389-390
Journal	European journal of cancer & clinical oncology
Volume	25
Issue number	2
DOIs	https://doi.org/10.1016/0277-5379(89)90035-7
Publication status	Published - 1989
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/0277-5379(89)90035-7

Cite this

@article{1842a0d2481c46b2a9b3ffe8e5af44a1,

title = "A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU group protocol 30867",

author = "Foss{\aa}, \{Sophie D.\} and Ted Splinter and Roozendaal, \{Klaas J.\} and Veenhof, \{Kees H. N.\} and Michele Pavone-Macaluso and Alessandro Calciati and \{de Pauw\}, Marleen and Richard Sylvester",

year = "1989",

doi = "10.1016/0277-5379(89)90035-7",

language = "English",

volume = "25",

pages = "389--390",

journal = "European journal of cancer \& clinical oncology",

issn = "0277-5379",

publisher = "Pergamon Press",

number = "2",

}

TY - JOUR

T1 - A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU group protocol 30867

AU - Fosså, Sophie D.

AU - Splinter, Ted

AU - Roozendaal, Klaas J.

AU - Veenhof, Kees H. N.

AU - Pavone-Macaluso, Michele

AU - Calciati, Alessandro

AU - de Pauw, Marleen

AU - Sylvester, Richard

PY - 1989

Y1 - 1989

UR - https://www.scopus.com/pages/publications/0024509475

UR - https://www.ncbi.nlm.nih.gov/pubmed/2702991

U2 - 10.1016/0277-5379(89)90035-7

DO - 10.1016/0277-5379(89)90035-7

M3 - Article

C2 - 2702991

SN - 0277-5379

VL - 25

SP - 389

EP - 390

JO - European journal of cancer & clinical oncology

JF - European journal of cancer & clinical oncology

IS - 2

ER -

A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU group protocol 30867

UN SDGs

Access to Document

Other files and links

Cite this